Skip to main content
SpringerLink
Log in

In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole

  • Concise Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

In order to evaluate the suitability of fosfomycin in combination with other agents for the treatment of Helicobacter pylori infections, the susceptibility profiles of 65 H. pylori strains were determined against multiple antimicrobial agents and combinations thereof using the agar dilution method. For fosfomycin alone, the range of minimum inhibitory concentration (MIC) results and the MICs at which 50% and 90% of strains were inhibited were 0.5–32 μg/ml and 2 and 4 μg/ml, respectively. For the combination of fosfomycin with amoxicillin, clarithromycin or metronidazole, the means calculated for the minimum and maximum fractional inhibitory concentration index were 0.70–1.17 and 1.15–2.03, respectively, suggesting partial synergy or indifference in the majority of strains. The combination of clarithromycin and metronidazole showed synergistic activity against 14 of 28 H. pylori strains tested. The in vitro activity results suggest the combination of fosfomycin with either amoxicillin or clarithromycin may be a promising alternative for the treatment of H. pylori infection. However, the clinical efficacy of these regimens remains to be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Megraud F (2001) Resistance of Helicobacter pylori to antibiotics and its impact on treatment options. Drug Resistance Updates 4:178–186

    Google Scholar 

  2. Philipp W, Kofler J (1986) Untersuchung des Penetrationsvermögens von Fosfomycin in das Kammerwasser und den Glaskörper des Auges. Klinische Monatsblätter für Augenheilkunde 189:240–242

    Google Scholar 

  3. Haag R, Hölzlberger R, Rienhoff E, Bartels F, Meissner A (1989) Experimentelle Untersuchungen und Überlegungen zur Verteilung und verzögerten Freisetzung von Fosfomycin aus Knochengewebe. ZAC Zeitschrift für antimikrobielle antineoplastische Chemotherapie 7:3–10

    Google Scholar 

  4. Frossard M, Joukhadar C, Erovic BM, Dittrich P, Mrass PE, van Houte M, et al (2000) Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob Agents Chemother 44:2728–2732

    Google Scholar 

  5. Drugeon H, Baron D, Chung Courtieu A (1980) The resistance to fosfomycin by mutation. A study in vitro. Clinical consequences. Drugs Exp Clin Res 6:345–349

    Google Scholar 

  6. National Committee for Clinical Laboratory Standards (2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th edn. Approved Standard M7-A5. NCCLS, Villanova, PA, USA

    Google Scholar 

  7. Hirschl AM, Apfalter P, Makristathis A, Rotter M, Wimmer M (2000) In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 44:1977–1979

    Google Scholar 

  8. Moody JA (1991) Synergism testing. Broth microdilution checkerboard and broth macrodilution methods. In: Isenberg HD (ed) Clinical microbiology procedures handbook. Vol. 1. 1. American Society for Microbiology, Washington, D.C., USA. pp.5.18.1–5.18.28

    Google Scholar 

  9. Andrews JM, Baquero F, Beltran JM, Canton E, Crokaert F, Gobernado M, et al (1983) International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother 12:357–361

    Google Scholar 

  10. Gallego A, Rodriguez A, Mata M (1974) Fosfomycin: pharmacological studies. Drugs of Today 10(Suppl 11):161–168

    Google Scholar 

  11. Lind T, Mégraud F, Unge P, et al (1999) The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 116:248–253

    Google Scholar 

  12. Malfertheiner P, Mégraud F, O’Morain C, et al and the European Helicobacter pylori Study Group (2002) Current concepts in the management of Helicobacter pylori infection – The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16:167–180

    Google Scholar 

  13. Bazzoli F, Pozzato P, Rokkast T (2002) Helicobacter pylori: the challenge in therapy. Helicobacter 7(Suppl1):43–49

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hygiene and Medical Microbiology, Division of Hospital Hygiene, Medical University Vienna, Waehringer Guertel 18–20, 1090, Vienna, Austria

    A. Blacky

  2. Department of Hygiene and Medical Microbiology, Division of Clinical Microbiology, Medical University Vienna, Waehringer Guertel 18–20, 1090, Vienna, Austria

    A. Makristathis, P. Apfalter, B. Willinger, M. L. Rotter & A. M. Hirschl

Authors
  1. A. Blacky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Makristathis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Apfalter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Willinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. L. Rotter
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. M. Hirschl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Blacky.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blacky, A., Makristathis, A., Apfalter, P. et al. In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole. Eur J Clin Microbiol Infect Dis 24, 276–279 (2005). https://doi.org/10.1007/s10096-005-1307-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-005-1307-9

Keywords

Search

Navigation